Publications: Reprints
are available
1. Orimo S., Araki M, Ishii H, Ikeda M et al. A case
of myopathy with tubular aggregates with increased muscle fiber sensitivity
to caffeine. J Neurol 1987;234:424-426.
2. Ikeda M, Mikuni M, Nishikawa T, Takahashi K. A neurochemical
study of a new mutant mouse presenting myoclonus-like involuntary movement:
a possible model of spontaneous serotonergic hyperactivity. Brain Res 1989;495:337-348.
3. Uchihara T, Ikeda M, Takahashi H, Yoshida S, Tsukagoshi
H. CSF lymphocyte subsets in aseptic meningitis: dual labelling analysis
with flow cytometry. Acta Neurol Scand 1990;81:468-470.
4. Ikeda
M, Tsukagoshi H. Encephalopathy due to toluene sniffing, Report
of a case with magnetic resonance imaging. Eur Neurol 1990;30:347-349.
5. Kurumaji A, Ikeda M, Dewar D, McCormac AG, McCulloch
J. Effects of chronic administration of MK-801 upon local cerebral glucose
utilization and ligand binding to the NMDA receptor complex. Brain Res
1991;563:57-65.
6. Uchihara T, Ikeda M, Tsukagoshi H. Recurrent Fisher's
syndrmoe with immunological abnormalities and replicated laterality. Eur
Neurol 1991;31:270-272.
7. Ikeda M, Dewar D, McCulloch J.
Selective reduction of [125I]-apamin binding sites in Alzheimer hippocampus,
A quantitative autoradiographic study. Brain Res 1991;567:51-56.
8. Ikeda M, Dewar D, McCulloch J. Preservation of [125I]-galanin
binding sites despite loss of cholinergic neurones in Alzheimer's disease.
Brain Res 1991;568:303-306.
9. Ikeda M, Tsukagoshi H. Monochorea caused by striatal
lesion. Eur Neurol 1991;31:257-258.
10. Ikeda M, Tsukagoshi H. Vogt-Koyanagi-Harada disease
presenting meningoencephalitis, Report of a case with magnetic resonance
imaging. Eur Neurol 1992;32:83-85.
11. Ikeda M, Yoshida S, Tsukagoshi H. Interferon-g in
cerebrospinal fluid without pleocytosis in scrub typhus. J Neurol Sci 1992;109:61-63.
12. Ikeda M, Dewar D, McCulloch J. A correlative study
of calcium channel antagonist binding and local neuropathological features
in the hippocampus in Alzheimer's disease. Brain Res 1992;589:313-319.
13. Ikeda M, Dewar D, McCulloch J. Differential alterations
of multiple ion channel binding sites in the cerebral cortex in Alzheimer's
disease. J Cereb Blood Flow Metab 1993;13:s247.
14. Sato I, Morita I, Kaji K, Ikeda M, Nagao M, Murota
S. Reduction of nitric oxide producing activity associated with aging in
cultured human umbilical vein endothelial cells. Biochem Biophys Res Commun
1993;195:1070-1076.
15. Ikeda M, Dewar D, McCulloch J. High affinity hippocampal
[3H]-glibenclamide binding sites are preserved in Alzheimer's disease.
J Neural Transm [P-D Sect] 1993;5:177-184.
16. Ikeda M, Morita I, Murota S, Sekiguchi F, Yuasa T,
Miyatake T. Cerebellar nitric oxide synthase activity is reduced in nervous
and Purkinje cell degeneration mutants but not in climbing fiber-lesioned
mice. Neurosci Lett 1993;155:148-150.
17. Ikeda M, Dewar D, McCulloch J. Differential alterations
of ion channel binding sites in temporal and occipital regions of the cerebral
cortex in Alzheimer's disease. Brain Res 1993;630:50-56.
18. Ikeda M, Mackay KB, Dewar D, McCulloch J. Differential
alterations in adenosine A1 and k1 opioid receptors in the striatum in
Alzheimer's disease. Brain Res 1993;616:211-217.
19. Ikeda M, Matsui K, Ishihara Y, et al. Cerebellar
nitric oxide synthase, cGMP and motor function in two lines of cerebellar
mutant mice, Staggerer and Wriggle Mouse Sagami. Neurosci Lett 1994;168:65-68.
20. Ikeda
M, Takahashi K, Matsunaga T, Tsukagoshi H. Reversible white matter
lesions in a patient with fulminant hepatitis and acute renal failure.
Intern Med 1994;33:360-362.
21. Ikeda M, Takahashi H, Yoshida S. HLA-DR+CD3+ and
CD8+ cells are increased but CD4+CD45RA+ cells are reduced in the peripheral
blood in human scrub typhus. Clin Immunol Immunopathol 1994;72:402-404.
22. Komachi H, Tsuchiya K, Ikeda M, Koike R, Matsunaga
T, Ikeda K. Radiation myelophathy: a clinicopathological study with special
reference tjo correlation between MRI findings and neuropathology. J Neurol
Sci 1995;132:228-232.
23. Ikeda M, Dewar D, McCulloch J. Galanin receptor binding
sites in the temporal and the occipital cortex are minimally affected in
Alzheimer's disease. Neurosci Lett 1995;192:37-40.
24. Ikeda M, Sato I, Yuasa T, Miyatake T, Murota S. Nitrite,
nitrate and cGMP in the cerebrospinal fluid in degenerative neurologic
diseases. J Neural Transm [Gen Sect] 1995;100:263-267.
25. Ikeda
M, Sato I, Matsunaga T, Takahashi M, Yuasa T, Murota S. cGMP, nitrite
and nitrate in the cerebrospinal fluid in meningitis, multiple sclerosis
and Guillain-Barré syndrome. Intern Med 1995;34:734-737.
26. Himi T, Ikeda M, Sato I, Yuasa T, Murota S. Purkinje
cells express neuronal nitric oxide synthase after methylmercury administration.
Brain Res 1996;718:189-192.
27. Ikeda M, Kanai H, Akaike M, et al. Nitric oxide synthase-containing
neurons in the hippocampus are preserved in trimethyltin intoxication.
Brain Res 1996;712:168-170.
28. Kanai H, Ikeda M, Akaike M, et al. Reaction of NO-synthase
cotaining cells in the rat hippocampus following trimethyltin (TMT) exposure.
In: Kato N, ed. The hippocampus: Function and Clinical Relevances.Amsterdam:
Elsevier, 1997.
29. Ikeda M, Komachi H, Sato I, Himi T, Yuasa T, Murota
S. Induction of neuronal nitric oxide synthase by methylmercury in the
cerebellum. J Neurosci Res 1999;55:352-356.
30. Ikeda M, Komiyama T, Sato I, Himi T, Murota S. Neuronal
nitric oxide synthase is resistant to ethanol. Life Sci 1999;64:1623-1630.
31. Tsuchiya K, Ozawa E, Haga C, Watabiki, S, Ikeda M,
Sano M, Ooe K, Taki K, Ikeda, K. Constant involvement of the Betz cells
and pyramidal tract in multiple system atrophy: a clinicopathological study
of seven autopsy cases. Acta Neuropathol 2000;99: 628-636
32. Suzuki R, Ikeda M, Kami M. Japanese physicians and
public respect. Lancet 2000;356:598-600.
33. Himi T, Ikeda M, Murota S. P2-62 Glutamate uptake
inhibitor L-trans-pyrrolidine 2,4-dicarboxylate induces free radical generation
and glutathione deprivation in cultured hippocampal neurons. Neurochem
Res 2000;25:1062-63.
34. Ikeda M and Yoshida S.
HIV suppression by scrub typhus. Lancet 2000;356:1851
35. Ikeda
M.
Iron overload without the C282Y mutation in patients with epilepsy. J Neurol
Neurosurg Psychiat 2001;70:551-553.
36. Ikeda
M, Arai Y. Longitudinal changes in brain CT scans and development
of dementia in Down's syndrome. Eur Neurol 2002; 47:205-208
37.
Ikeda
M, MatsunagaT, Irabu N, Yoshida S. Using vital signs to diagnose
impaired consciousness: cross sectional observational study. BMJ 2002;325:800
38. Himi T, Ikeda M, Yasuhara T, Murota
S. Oxidative neuronal death caused by glutamte uptake inhibition in cultured
hippocampal neurons. J Neurosci Res 2003;71:679-688
39. Himi T, Ikeda M, Yasuhara T, Morita
I. Role of Neuronal Glutamate Transporter in the Cysteine Uptake and Intracellular
Glutathione Levels in Cultured Cortical Neurons. J Neural Transm [Gen Sect]
2003;110: 1337-48
40.Kishi
Y, Miyakoshi S, Kami M, Ikeda M, Katayama Y, Murashige N, Kusumi E, Yuji
K, Kobayashi K, Kato D, Hamaki T, Matsumura T, Kim SW, Morinaga S, Mori
S, Kanemaru M, Hayashi T, Takaue Y, Taniguchi S; Tokyo Stem Cell Transplantation
Consortium. Early central nervous system complication following reduced
intensity stem-cell transplantation. Biol Blood Marrow Transplant 2004
;10:561-8.
41. Ikeda
M. Family bias by proxy. Lancet 2005;365:187
42. Kobayashi
K, Kami M, Ikeda M, Kishi Y, Murashige N, Tanosaki R, Mori S, Takaue
Y. Fulminant septicemia caused by Bacillus cereus following reduced-intensity
umbilical cord blood transplantation. Haematologica 2005;90:ECR06
43. Murashige
N, Kami M, Ikeda M. Aspirin, COX-2, and the Risk of Colorectal
Cancer. N Engl J Med 2007;357: 824.
44. Kondoh
T, Kanno A, Itoh H, Nakashima M, Honda R, Kojima M, Noguchi M, Nakane H,
Nozaki H, Sasaki H, Nagai T, Kosaki R, Kakee N, Okuyama T, Fukuda M, Ikeda
M, Shibata Y, Moriuchi H. Donepezil Significantly Improves Abilities
in Daily Lives of Female Down Syndrome Patients with Severe Cognitive Impairment:
A 24-Week Randomized, Double-Blind, Placebo-Controlled Trial. Int J Psychiatry
Med 2011;41:71-89.
45. Shimazawa R, Ikeda
M. Japan lags behind the UK in neurological drug approvals. Br
J Clin Pharmacol 2011;71:473-475
46. Ikeda
M. Fulminant form of mitochondrial myopathy, encephalopathy, lactic
acidosis, and stroke-like episodes: A diagnostic challenge. J Med Cases
2011;2(2):87-90.
47. Shimazawa
R, Ikeda M. Delays in neurological drug development in Japan.
Internal Medicine 2011;50: 1565-1568.
48. Shimazawa
R, Ikeda M. Medical management of the acute radiation syndrome.
Ann Intern Med 2011;155:135-6
49. Shimazawa
R, Ikeda M. Drug development against chemical, biological,
radiological, or nuclear agents. Lancet 2011;378:486.
50. FujiwaraT,
Nishimura M, Honda R, Nishiyama T, Nomoto M, Kobayashi N, Ikeda M.
Comparison of peer-led versus professional-led training in basic life support
for medical students. Advances in Medical Education and Practice 2011;2:187–191.
51. Shimazawa
R, Kusumi I, Ikeda M. Delays in psychiatric drug development in
Japan. J Clin Pharm Ther 2012;37:348-351.
Massie's Home